Radiation Oncology/Therapy: Page 5

Nuclidium wins award to study NET radiopharmaceutical

By AuntMinnieEurope.com staff writers

Radiopharmaceutical developer Nuclidium and the University Hospital Basel, Switzerland, have received an Investigator Award from the Neuroendocrine Tumors Research Foundation to support a phase I trial of its TraceNET copper-based diagnostic radiopharmaceutical for neuroendocrine tumors (NETs).

March 20, 2023

Curium comments on supply challenges for Eclipse clinical trial

By AuntMinnieEurope.com staff writers

Nuclear medicine company Curium confirmed in a recent statement that it doesn't expect supply challenges of its lutetium-177 prostate-specific membrane antigen with 3-iodo-D-tyrosine for the company's Eclipse phase III clinical trial.

March 19, 2023

European companies to develop strategies for dismantling cyclotrons

By AuntMinnieEurope.com staff writers

A group of European companies plans to develop "turnkey" options for dismantling aging cyclotrons, according to an article in the Brussels Times.

March 12, 2023

Will lecanemab approval increase PET scan volumes?

By Will Morton

Europe could see increased demand for PET imaging if the monoclonal antibody lecanemab receives regulatory approval for the treatment of Alzheimer's disease, the European Association for Nuclear Medicine has stated.

March 12, 2023

How effective is MRI for planning colorectal cancer surgery?

By Kate Madden Yee

VIENNA - Preoperative MRI helps surgeons predict whether colorectal cancer structures -- for example, the omentum and ovaries, the pelvic peritoneum, or the ileum -- can be effectively removed, according to research presented at ECR 2023.

March 2, 2023

Can older women skip radiotherapy for breast cancer treatment?

By Amerigo Allegretto

Skipping radiotherapy is a potential option for older women with early-stage breast cancer, a research group based at the University of Edinburgh in Scotland has stated in a paper posted on 16 February.

February 19, 2023

PET/MRI proves effective for lymphoma management

By Will Morton

PET/MRI is becoming an increasingly viable and practical alternative to PET/CT in the routine management of lymphoma patients, a group of Australian investigators have found.

February 5, 2023

Diederich puts spotlight on role of oncologic imaging

By AuntMinnieEurope.com staff writers

Oncologic imaging methods look set to play an increasingly significant role in cancer treatment efficacy, Prof. Dr. Stefan Diederich has said in a wide-ranging interview posted by the German Radiological Society.

February 2, 2023

European Federation for Cancer Images group expands

By AuntMinnieEurope.com staff writers

Philips Healthcare has joined the European Federation for Cancer Images consortium, a cornerstone project in the European Cancer Imaging Initiative launched officially last week by the European Commission.

February 1, 2023

Europe launches radiology AI initiative for cancer imaging

By Erik L. Ridley

The European Commission has launched the European Federation for Cancer Images, a four-year scheme that aims to enhance the use of imaging and artificial intelligence (AI) for precision medicine in cancer patients.

January 24, 2023

Dual-energy CT offers low-dose alternative to perfusion CT

By Kate Madden Yee

Dual-energy CT performs comparably to high-dose perfusion CT for assessing angiogenesis of lesions resulting from solitary lung nodules, according to a Polish study published on 4 January in Scientific Reports.

January 9, 2023

German group confirms promise of FAPI-PET for identifying cancer

By Will Morton

Researchers from the University of Duisburg-Essen in North Rhine-Westphalia have reported that gallium-68 fibroblast activation protein inhibitor (FAPI) PET imaging may improve tumor detection in cancer patients compared with conventional techniques.

January 5, 2023

Previous Page

Page 5 of 127

Next Page